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Background. Giardia are among the most common enteropathogens detected in children in low-resource settings. We describe 
here the epidemiology of infection with Giardia in the first 2 years of life in the Etiology, Risk Factors, and Interactions of Enteric 
Infections and Malnutrition and the Consequences for Child Health and Development Project (MAL-ED), a multisite birth-cohort 
study.
Methods. From 2089 children, 34 916 stool samples collected during monthly surveillance and episodes of diarrhea were tested 
for Giardia using an enzyme immunoassay. We quantified the risk of Giardia detection, identified risk factors, and assessed the 
associations with micronutrients, markers of gut inflammation and permeability, diarrhea, and growth using multivariable linear 
regression.
Results. The incidence of at least 1 Giardia detection varied according to site (range, 37.7%–96.4%) and was higher in the sec-
ond year of life. Exclusive breastfeeding (HR for first Giardia detection in a monthly surveillance stool sample, 0.46 [95% confidence 
interval (CI), 0.28–0.75]), higher socioeconomic status (HR, 0.74 [95% CI, 0.56–0.97]), and recent metronidazole treatment (risk 
ratio for any surveillance stool detection, 0.69 [95% CI, 0.56–0.84]) were protective. Persistence of Giardia (consecutive detections) 
in the first 6 months of life was associated with reduced subsequent diarrheal rates in Naushahro Feroze, Pakistan but not at any 
other site. Giardia detection was also associated with an increased lactulose/mannitol ratio. Persistence of Giardia before 6 months 
of age was associated with a −0.29 (95% CI, −0.53 to −0.05) deficit in weight-for-age z score and −0.29 (95% CI, −0.64 to 0.07) deficit 
in length-for-age z score at 2 years.
Conclusions. Infection with Giardia occurred across epidemiological contexts, and repeated detections in 40% of the children 
suggest that persistent infections were common. Early persistent infection with Giardia, independent of diarrhea, might contribute 
to intestinal permeability and stunted growth.
Keywords. children; Giardia; growth; intestinal permeability; risk factors. 
INTRODUCTION
Giardia lamblia, also known as Giardia duodenalis and Giardia 
intestinalis, is the most common etiology of intestinal para-
sitic infection in the first 2 years of life in low-resource settings. 
Although Giardia is a recognized pathogen of waterborne diar-
rhea outbreaks [1] and a common cause of diarrhea among trav-
elers [2–4] and after recreational water exposure [5], the impact 
of endemic pediatric giardiasis is less clear. Two large studies 
of global etiologies of endemic pediatric diarrhea, the Global 
Enterics Multicenter Study (GEMS) [6] and the Etiology, Risk 
Factors, and Interactions of Enteric Infections and Malnutrition 
and the Consequences for Child Health and Development Project 
(MAL-ED) [7], found Giardia significantly more often in nondi-
arrheal than diarrheal stools. Similarly, Giardia was not associated 
with acute diarrhea in a meta-analysis of 12 acute pediatric diar-
rhea studies [4], and Giardia had a protective effect against acute 
diarrhea in 2 longitudinal studies [8, 9].
Evidence for an association between Giardia infection and 
child growth outcomes has been mixed [10–15]. Giardia infec-
tion is associated with disrupted villus architecture [16], an 
elevated lactulose/mannitol ratio (a marker of intestinal perme-
ability) [17, 18], and zinc and vitamin A deficiencies [19–21], 
which suggests gut dysfunction and inadequate nutrient uptake. 
These associations, however, have been inconsistent and limited 
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in ascribing directionality, because vitamin A  deficiency, for 
example, can increase susceptibility to Giardia infection [22].
The multisite MAL-ED birth-cohort study [23] provides 
high-resolution prospective data to clarify early-life Giardia 
epidemiology in high-prevalence settings. Longitudinal analy-
sis specifically enables assessment of the temporality between 
detection of Giardia, diarrhea, micronutrient status, markers of 
intestinal permeability and inflammation, and the estimation 
of longer-term effects on growth. Here, we describe the deter-
minants, burden, and impact of Giardia infection in the first 
2 years of life in 8 low-resource sites.
METHODS
The MAL-ED study design and methods have been described 
[23]. In brief, the study was conducted between November 
2009 and February 2014 at sites in Dhaka, Bangladesh (BGD), 
Fortaleza, Brazil (BRF), Vellore, India (INV), Bhaktapur, Nepal 
(NEB), Naushahro Feroze, Pakistan (PKN), Loreto, Peru (PEL), 
Venda, South Africa (SAV), and Haydom, Tanzania (TZH). 
Children were followed from birth (<17 days of age) via twice-
weekly home visits for illness surveillance, medicines, and 
breastfeeding practices and monthly for anthropometry until 
they reached 2 years of age [24]. Nondiarrheal surveillance 
stool samples were collected and tested for 40 enteropathogens 
[25] monthly in the first year (0–12 months) of life and quar-
terly in the second year (12–24 months) of life. Stool samples 
were collected and tested also during every diarrhea episode 
reported during the twice-weekly surveillance visits. Diarrhea 
was defined as maternal report of 3 or more loose stools in 24 
hours or 1 stool with visible blood [24]. Weight-for-age (WAZ) 
and length-for-age (LAZ) z scores were calculated using the 
2006 World Health Organization child growth standards [26]. 
Sociodemographic information was assessed biannually and 
summarized using the Water, Assets, Maternal Education, 
Income (WAMI) score, which is based on monthly household 
income, maternal education, wealth measured by 8 assets, and 
access to improved water and sanitation [27], as defined by 
World Health Organization guidelines [28]. Plasma zinc and ret-
inol concentrations were assessed at 7, 15, and 24 months of age 
[29]. Urinary lactulose/mannitol excretion ratios, measured at 
3, 6, 9, and 15 months of age, were converted into  sample-based 
z scores (LMZs) using the BRF cohort as the internal reference 
population [30]. All sites received ethical approval from their 
respective governmental, local institutional, and collaborating 
institutional ethical review boards. Informed written consent 
was obtained from the parent or guardian of each child.
Data and Definitions
We included in the analysis all monthly surveillance and diar-
rheal stool samples that were tested for Giardia by enzyme 
immunoassay (EIA) (TechLab, Blacksburg, VA), the majority of 
which were also tested by wet-prep microscopy. The laboratory 
methods for detecting other enteropathogens and gut biomark-
ers, including α-1-antitrypsin (ALA), myeloperoxidase (MPO), 
neopterin (NEO), and α-1-acid glycoprotein (AGP), a marker 
of systemic inflammation, have been described [25, 29, 31].
Definitions of incident Giardia-related diarrhea were defined 
with increasing specificity for diarrhea of true Giardia etiology 
as follows: (1) Giardia-positive diarrhea, Giardia was detected 
in a diarrheal stool sample; (2) new Giardia-positive diar-
rhea, Giardia was detected in a diarrheal stool sample, and the 
most recent previous stool sample tested negative for Giardia 
or was taken more than 2 months earlier; (3) Giardia-positive 
diarrhea-associated pathogens–negative diarrhea, Giardia was 
detected in a diarrheal stool sample, but no diarrhea-associated 
pathogens that were previously identified in MAL-ED were 
detected (13 of 40 pathogens tested, ie, norovirus GII, rotavi-
rus, astrovirus, adenovirus, Campylobacter, Cryptosporidium, 
heat-stable enterotoxin-producing enterotoxigenic Escherichia 
coli, typical enteropathogenic E coli, heat-labile enterotox-
in-producing enterotoxigenic E coli, Shigella, enteroinvasive E 
coli, Entamoeba histolytica, and Salmonella [7]); and (4) Giardia-
positive-only diarrhea, Giardia was detected in a diarrheal stool 
sample, and no other enteropathogens among all 40 tested were 
detected [25]. Persistence of Giardia detection was defined as 
2 consecutive stool samples that tested positive for Giardia (2 
consecutive months in the first year of life or 2 consecutive 
quarters in the second year). Prolonged persistence was defined 
as 3 consecutive stool samples that tested positive for Giardia.
Data Analysis
Risk factors for the first detection of Giardia in surveillance 
stool samples were identified using pooled logistic regression 
to estimate hazard ratios (HRs) and adjusting for site and a 
restricted quadratic spline [32] for age. Variables in the multi-
variable model were included on the basis of statistical signifi-
cance, model fit by the quasi-likelihood information criterion, 
covariance between factors, and variability of factors within sites 
for site-specific models. Comparing by the Akaike information 
criterion (AIC) to models with linear week of the year, season-
ality was assessed by modeling Giardia detection with linear, 
quadratic, and cubic terms for the week of the year (w), and the 
terms sin(2πw/52), cos(2πw/52), sin(4πw/52), and cos(4πw/52). 
We used Poisson regression to evaluate associations between 
zinc and vitamin A status with Giardia detection in surveil-
lance stool samples and adjusted for previous Giardia detection 
and potential confounders included in the multivariable risk 
factor model. We estimated the effect of Giardia detection on 
subsequent diarrheal rates using pooled logistic regression with 
general estimating equations (GEEs) and robust variance to 
account for correlation between outcomes within children and 
adjusted for the same confounders and illness symptoms during 
the exposure periods. We estimated the effect of Giardia in all 
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stools on gut biomarker concentrations using multivariable 
linear regression with GEEs and adjusted for stool consistency 
and presence of the 2 other pathogens of highest prevalence, 
enteroaggregative E coli (EAEC) and Campylobacter. Last, we 
estimated the effect of Giardia detection in surveillance stools 
on WAZ and LAZ attainment at 2 years of age using multivari-
able linear regression with GEEs. Confounders, listed in the 
table footnotes, included baseline sociodemographic charac-
teristics associated with Giardia detection identified above and 
EAEC and Campylobacter stool positivity. Data from SAV were 
excluded from zinc-related analyses and data from PKN were 
excluded from length-related analyses because of measurement 
quality concerns at those sites. For analyses limited to surveil-
lance stool samples, results (not shown) were consistent when 
we repeated analyses with diarrheal stool samples.
RESULTS
Diagnostics
Of 34 916 stool samples (27 092 surveillance and 7824 diarrheal) 
tested for Giardia by an EIA, 33 796 (96.8%) were also tested for 
Giardia by wet-prep microscopy. Compared to EIA, the sensi-
tivity of microscopy was 46.2%, and its specificity was 99.3%. 
Giardia positivity by microscopy was 21% less likely if the stool 
was watery or liquid than if it was soft or formed (risk ratio 
[RR], 0.79 [95% confidence interval (CI), 0.68–0.90]), but we 
found no association between stool consistency and EIA results 
(RR, 0.94 [95% CI, 0.86–1.03]).
Incidence and Persistence
Among 2089 children with at least 1 tested stool, the overall 
Giardia prevalence according to the EIA in stool samples was 
14.7% (n  =  5135). Giardia was detected at least once in two-
thirds (n = 1178) of the 1741 children followed to 2 years of age 
(range, 37.7% [BRF] to 96.4% [PKN]). The overall median times 
to Giardia detection, which varied according to site, were 18.0 
and 20.0 months for surveillance and diarrheal stool samples, 
respectively (Figure 1).
The incidence of Giardia-positive diarrhea was 40.4 cases 
per 100 person-years. However, measures of Giardia-related 
diarrhea incidence decreased by approximately 60%, 75%, and 
more than 80% when we required the previous stool sample 
to have tested negative for Giardia, the current stool sample to 
have no detection of diarrhea-associated pathogens, and the 
current stool sample to have no detection of any other patho-
gens, respectively (Table 1).
The overall prevalence of Giardia detected in surveillance 
stool samples was 13.6% (Table 1). However, the prevalence 
decreased by more than half (6.0%) when we required the pre-
vious surveillance stool to have tested negative for Giardia. 
Repeated Giardia detections in surveillance stool samples 
occurred in 838 (40.1%) children (Supplementary Figure 1). 
The prevalence of persistence was less than 5% before 6 months 
of age in all except the PKN site but increased to 31.8% overall 
in the second year of life.
Risk Factors
Giardia detection increased with age over the first 2 years of life; 
a 1-month increase in age was associated with an 11% increase in 
the risk of Giardia detection in surveillance stool samples (RR, 1.11 
[95% CI, 1.10–1.12]). The percentage of days in the previous month 
that the child was exclusively breastfed was a strongly protective 
factor against first Giardia detection (Table  2). Socioeconomic 
factors, including increased socioeconomic score (Water, Assets, 
Maternal Education, Income score [27]), household income, and 
older maternal age, were also protective. Metronidazole exposure 
in the previous 15 days was associated with a 31% relative decrease 
(95% CI, 16–44) in Giardia detection in surveillance stool samples, 
Figure 1. Cumulative incidence of Giardia detection in surveillance and diarrheal stool samples across all sites (A) and in surveillance stool samples within 
each site (B) among 2089 children in the Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health 
and Development Project (MAL-ED) cohort with at least 1 stool tested for Giardia.
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but we found no association with exposure more than 15 days ear-
lier or with exposure to any other antibiotics.
Multiple hygiene and environmental risk factors were associ-
ated with Giardia detection. Hand-washing, treatment of drink-
ing water, and increased water access were protective, whereas 
the presence of siblings was a strong risk factor. Associations 
with having a dirt floor and owning chickens indicate the 
importance of environmental exposure to Giardia (Table 2). The 
distribution of environmental factors differed according to site, 
and although risk factor trends were generally consistent, there 
were site-to-site variations in the magnitude and even the direc-
tion of associations in some cases (Supplementary Figure 2).
Giardia was positively correlated with Campylobacter detec-
tion (Pearson correlation coefficient [PCC], 0.15; P  <  .0001) 
but not with the detection of EAEC (PCC, −0.02; P = .0001) or 
viruses (PCC, −0.00; P  =  .7) in all stool samples, which sug-
gests that the routes of transmission and/or age-susceptibility 
patterns are similar to those of Campylobacter.
Seasonality
We found a significant increase in first Giardia detections in 
surveillance stool samples in July through September and a 
smaller peak in March/April in the south Asian sites (BGD, 
INV, NEB, and PKN) (Supplementary Figure 3). Giardia sea-
sonality was variable at the other sites, with peaks in December/
January in the BRF and PEL sites and a small peak in March/
April in the TZH and SAV sites. In contrast, we found no 
evidence of seasonality when we included all Giardia detec-
tions. No association between site-specific mean temperature 
or rainfall and Giardia positivity was found. The seasonality 
of Giardia detection in diarrheal stool samples matched the 
seasonality of all-cause diarrhea, which suggests that many 
Giardia-positive diarrheal episodes were caused by other 
pathogens (not shown).
Zinc, Vitamin A, and Giardia
Higher plasma zinc and retinol concentrations at 7  months of 
age were associated with decreased subsequent Giardia detec-
tion (Supplementary Table 1). A combined 1 standard deviation 
greater zinc and retinol concentration was associated with an 
adjusted 22% (95% CI, 2%–37%) lower Giardia-detection rate in 
surveillance stool samples from 8 to 24 months of age. A higher 
retinol concentration at 15 months of age was also associated with 
an approximate 10% decrease in the subsequent Giardia-detection 
rate. There were no associations between zinc status and Giardia 
detection at 15 months of age and no associations at either time 
period between zinc or vitamin A status and incidence of Giardia-
positive diarrhea.
Giardia detection in surveillance stool samples in the period 
between vitamin A  status measurements at 7 and 15  months 
was associated with an adjusted −1.58 mg/dL (95% CI, −2.82 
to −0.34 mg/dL) change in retinol concentration over that time 
period. There were no associations between Giardia and change 
in zinc concentration.
Giardia and Risk of Acute Diarrhea
Giardia detection in surveillance stool samples was not associ-
ated with short-term diarrheal risk (adjusted RR for diarrhea in 
the following 30 days, 1.07 [95% CI, 0.96–1.19]). In addition, the 
apparent negative association between Giardia detection and diar-
rhea previously reported (RR adjusted for age and site, 0.90 [95% 
CI, 0.86–0.95]) [7] might be explained by treatment of 37% of all 
diarrhea episodes with metronidazole, such that Giardia might 
have been cleared before the diarrheal stool was collected. When 
Table 1. Prevalence of Giardia Detection in Surveillance Stools and Incidence of Giardia-Related Diarrhea According to Site Among 2089 Children in 
the MAL-ED Birth Cohort
Site
Prevalence (%) of Giardia Detection 
in Monthly Surveillance Stools
Incidencea of Giardia- 
Positive Diarrhea
Incidencea of New Giardia- 
Positive Diarrheab
Incidencea of Giardia-Positive Diarrhea- 
Associated Pathogens–Negative 
Diarrheac
Incidencea of Giardia-Positive- 
Only Diarrhead
BGD 4.2 22.8 (18.7–27.7) 12.3 (9.4–16.1) 1.8 (0.9–3.6) 1.4 (0.6–3.0)
BRF 7.3 4.6 (2.9–7.4) 1.8 (0.9–3.8) 1.5 (0.7–3.4) 1.0 (0.4–2.8)
INV 13.1 21.4 (17.6–26.1) 8.1 (5.9–11.2) 6.6 (4.6–9.4) 4.4 (2.8–6.8)
NEB 9.2 18.2 (14.6–22.6) 7.5 (5.4–10.5) 6.6 (4.6–9.5) 5.1 (3.4–7.7)
PEL 16.4 115.8 (106.3–126.2) 40.4 (34.9–46.7) 28.7 (24.1–34.0) 18.7 (15.1–23.2)
PKN 35.2 126.2 (116.3–136.9) 42.5 (36.9–48.9) 28.3 (23.8–33.6) 15.7 (12.4–19.7)
SAV 6.4 4.1 (2.6–6.3) 2.4 (1.4–4.3) 1.0 (0.4–2.4) 0.61 (0.20–1.9)
TZH 16.2 7.0 (5.0–9.9) 3.7 (2.3–6.0) 0.44 (0.11–1.8) 0.22 (0.03–1.6)
All 13.6 40.4 (38.4–42.5) 15.0 (13.8–16.3) 9.5 (8.5–10.5) 5.9 (5.2–6.8)
Abbreviations: BGD, Dhaka, Bangladesh; BRF, Fortaleza, Brazil; INV, Vellore, India; NEB, Bhaktapur, Nepal; PEL, Loreto, Peru; PKN, Naushahro Feroze, Pakistan; SAV, Venda, South Africa; TZH, Haydom, Tanzania.
aRate per 100 person-years.
bNew Giardia-positive diarrhea was defined if Giardia was detected in the diarrheal stool and the most recent previous stool tested negative for Giardia or was taken more than 2 months earlier (n = 539 of 1452 [37.1%] of all 
Giardia-positive diarrheal stools).
cGiardia-positive diarrhea-associated pathogens–negative diarrhea was defined if Giardia was detected in the diarrheal stool and no diarrhea-associated pathogens were detected (n = 341 of 1291 [26.4%] of all completely tested 
Giardia-positive diarrheal stools). Diarrhea-associated pathogens (norovirus GII, rotavirus, astrovirus, adenovirus, Campylobacter, Cryptosporidium, heat-stable enterotoxin-producing enterotoxigenic E coli, typical enteropatho-
genic E coli, heat-labile enterotoxin-producing enterotoxigenic E coli, Shigella, enteroinvasive E coli, E. histolytica, and Salmonella) were associated with diarrhea in the first or second year of life [7].
dGiardia-positive-only diarrhea was defined if Giardia was detected in the diarrheal stool and no other pathogens were detected (n = 214 of 1291 [16.6%] of all completely tested Giardia-positive diarrheal stool samples).
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we adjusted for recent metronidazole exposure, the association 
between Giardia detection and diarrhea moved toward the null 
(RR, 0.95 [95% CI, 0.90–1.00]).
Giardia detection was not associated with subsequent diar-
rheal rates in any except the PKN site (Supplementary Table 2). 
Giardia persistence before 6  months of age was common at 
the PKN site (17.4%) and was associated with an adjusted 28% 
relative decrease (95% CI, 11–41]) in diarrheal rates from 6 to 
24  months of age. Giardia persistence in the first year of life 
at the PKN site (47.7%) was also associated with an adjusted 
decrease in subsequent diarrheal rates (adjusted incidence rate 
ratio, 0.81 [95% CI, 0.64–1.03]). The protective effect was driven 
largely by protection against subsequent diarrhea in which 
enteropathogenic bacteria were detected.
Associations With Gut-Function Biomarkers
The presence of Giardia in stool samples was associated with 
an elevated marker of increased intestinal permeability, LMZ, 
across sites (Table 3), as indicated by an average increase in lac-
tulose (z-score difference, 0.12 [95% CI, −0.00 to 0.24]) and a 
decrease in mannitol (z-score difference, −0.15 [95% CI, −0.26 
to −0.04]). We found no significant differences in the associa-
tions across ages, although the magnitude was greatest in the 
second year of life (adjusted LMZ difference at 15 months, 0.25 
[95% CI, 0.10–0.40]). Among markers of inflammation, Giardia 
was also associated with a decrease in NEO concentration 
(Table 3) but not consistently with MPO, ALA, or AGP.
Effects on Growth
Giardia detection was associated with reduced weight and length 
attainment at 2 years of age (Table 4). Compared with those with 
low Giardia exposure (the 10th percentile of Giardia positivity in 
surveillance stool samples over the first 2 years of life), children 
with high exposure (the 90th percentile of Giardia positivity) 
had an adjusted −0.12 LAZ decrement (95% CI, −0.25 to 0.01) 
and −0.11 WAZ decrement (95% CI, −0.23 to −0.00) at 2 years 
of age. Giardia persistence in the first 6 months of life was statis-
tically significantly associated with more than double that dec-
rement in both weight and length at 24 months of age (Table 4).
DISCUSSION
The prospective MAL-ED birth-cohort study provided a unique 
opportunity to investigate the complex relationships between 
Giardia exposure, micronutrient status, intestinal permeability, 
diarrhea, and growth. Giardia detection was common at all sites 
and increased in frequency through the second year of life. Major 
reductions in Giardia diarrhea incidence when more specific 
definitions were used suggest that true Giardia-caused cases of 
diarrhea are difficult to identify in settings of high endemicity. 
In the absence of molecular typing, evidence of visual clustering 
of Giardia detections within children and seasonal patterns lim-
ited to first detections suggest that repeated detections can often 
represent persistent infections. We identified both hygiene and 
environmental risk factors for Giardia infection and confirmed 
Table 2. Risk Factors for First Giardia Detection in Monthly Surveillance 
Stool Samples Among 2088 Children in the MAL-ED Cohort With at Least 1 
Surveillance Stool
Risk Factor
Semi-Univariable 
(HR [95% CI])a
Multivariable  
(HR [95% CI])b
Child characteristics
 Female (vs male) 1.02 (0.89–1.16)
 Enrollment weight  
(per 1 z score)
1.05 (0.98–1.12)
 Exclusively breastfed since birth 0.67 (0.37–1.20)
 Percent days exclusively breastfed 
in last month (100% vs 0%)
0.43 (0.27–0.70) 0.46 (0.28–0.75)
 WAZ (per 1 z score)c 0.94 (0.88–1.00) 0.97 (0.91–1.03)
 LAZ (per 1 z score)c,d 0.96 (0.89–1.03)
 WLZ (per 1 z score)c,d 0.94 (0.88–1.00)
 Metronidazole used in  
previous 15 days
0.69 (0.47–1.01) 0.71 (0.48–1.04)
 Metronidazole used in  
previous 16–30 days 
1.02 (0.73–1.42)
Sociodemographic
 Socioeconomic score  
(WAMI [27], per 0.5 unit)
0.54 (0.42–0.69) 0.74 (0.56–0.97)
 Household income at or above  
site-specific median income
0.79 (0.69–0.91)
 Maternal age (per 5 y) 0.83 (0.75–0.93) 0.86 (0.77–0.96)
 Maternal education  
(≥6 y completed)
0.74 (0.64–0.86)
 Mother married 1.24 (0.95–1.60)
 Child has siblings 1.36 (1.18–1.57) 1.26 (1.09–1.46)
 Mean no. of people per room  
in the household (per 1 unit)
1.09 (1.04–1.16)
Water
 Improved (vs unimproved)  
drinking water [28]
0.95 (0.72–1.25)
 Time to access water (>10 min) 1.18 (0.97–1.44)
 Treated (vs untreated) water 0.69 (0.54–0.88) 0.78 (0.61–1.00)
Sanitation and hygiene
 Improved (vs unimproved)  
sanitation [28]
0.89 (0.71–1.10)
 Always washed hands after  
child defecated
0.79 (0.71–0.89) 0.80 (0.68–0.95)
 Always washed hands  
before preparing food
0.85 (0.77–0.95)
 Always washed hands  
after using toilet
0.82 (0.73–0.92)
 Used toilet paper 0.86 (0.76–0.98) 0.95 (0.83–1.08)
 Shared toilet facility 1.10 (0.89–1.35)
Environmental
 Dirt floor 1.34 (1.10–1.62) 1.13 (0.92–1.38)
 Household owned cows 1.04 (0.80–1.35)
 Household owned chickens 1.38 (1.12–1.70) 1.35 (1.10–1.66)
Abbreviations: CI, confidence interval; HR, hazard ratio; LAZ, length-for-age z score; WAMI, Water, Assets, 
Maternal Education, Income; WAZ, weight-for-age z score; WLZ, weight-for-length z score.
aAdjusted for site and age only (using restricted quadratic splines).
bAdjusted for site, age, and all other variables with estimates in this column (significant or strong association 
with Giardia detection in semi-univariable analysis, and not collinear with other variables).
cAt most recent measurement before stool collection.
dExcluding PKN.
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that the fecal-oral and waterborne routes both might be import-
ant modes of transmission. Host factors, including zinc and 
vitamin A deficiencies, might also contribute to Giardia suscep-
tibility, because children with higher micronutrient concentra-
tions had less subsequent Giardia detection. This relationship 
might be bidirectional, because Giardia detection from 7 to 15 
months of age was also associated with a decrease in retinol 
concentration during that period.
In contrast to data from previous reports [8, 9], our longitu-
dinal data did not suggest that Giardia infection was protective 
against diarrhea across the sites. The protective effect of Giardia 
on subsequent acute diarrheal risk was limited to early expo-
sures at the PKN site, which might be explained by the uniquely 
high detection rate in the first year of life at this site, environ-
ment-specific unidentified biological susceptibility factors, 
Giardia strain variability, and coinfection factors. Because the 
diagnostic EIA was insensitive to stool consistency, dilution of 
Giardia in diarrheal stools does not explain previously reported 
inverse associations with diarrhea [4, 7]. In contrast, clearance of 
Giardia in diarrheal stools by metronidazole, the most common 
antibiotic used for diarrhea treatment in MAL-ED (17% of all 
episodes were treated with metronidazole [33]), might contrib-
ute to this inverse association.
Even in the absence of diarrheal symptoms, Giardia infection, 
especially early persistent infection, was associated with reduced 
weight and height attainment at 2 years. This finding was reported 
recently from an independent cohort study in Bangladesh [34]. 
This early impact might be the result of a critical period of sus-
ceptibility in which the infant gut and intestinal microbiota are 
developing [35, 36]. The increased lactulose/mannitol excretion 
ratio associated with Giardia suggests a mechanism through 
increased intestinal permeability and malabsorption, components 
of environmental enteropathy [18]. Giardia was not associated 
with increased markers of intestinal inflammation (ALA, MPO, 
or NEO), which suggests that Giardia might disrupt epithelial cells 
through pathways different from those of chronic immune activa-
tion typical of environmental enteropathy. Given the divergence 
between diarrhea and growth outcomes associated with Giardia 
infection, diarrhea-independent mechanisms are likely responsi-
ble for the growth impact such that physiologic insult occurs with-
out necessary manifestation of diarrhea.
We found that the subset of children with early and per-
sistent Giardia infection experienced a significant disease bur-
den caused by Giardia. However, no association was observed 
between Giardia detection and growth in the comprehensive risk 
Table 4. Effects of Giardia Detection in Monthly Surveillance Stool 
Samples on Weight and Length Attainment at 2 Years of Age Among 1727 
Children in the MAL-ED Cohort With Anthropometric Measurements at 2 
Years
Exposure
n  
(N = 1727)
WAZ Differencea 
(95% CI)
LAZ Differencea,b  
(95% CI)
Giardia persistence in first 6 months 62 −0.29 (−0.53 to −0.05) −0.29 (−0.64 to 0.07)
Any Giardia detection in first 6 
months
173 −0.01 (−0.16 to 0.14) 0.08 (−0.12 to 0.28)
Giardia persistence in first year 290 −0.04 (−0.16 to 0.09) −0.01 (−0.15 to 0.13)
Any Giardia detection in first year 549 −0.07 (−0.18 to 0.03) −0.07 (−0.18 to 0.03)
Giardia persistence in second year 549 −0.05 (−0.15 to 0.05) −0.09 (−0.19 to 0.01)
Any Giardia detection in second year 976 −0.01 (−0.11 to 0.08) −0.05 (−0.14 to 0.05)
Any Giardia persistence 663 −0.05 (−0.15 to 0.04) −0.07 (−0.17 to 0.03)
Any Giardia detection 1101 −0.02 (−0.12 to 0.08) −0.04 (−0.13 to 0.06)
Any Giardia-related diarrheac 557 0.07 (−0.04 to 0.19) −0.03 (−0.15 to 0.10)
Percent positive surveillance stool 
samples (per 38% increased)
−0.11 (−0.23 to −0.00) −0.12 (−0.25 to 0.01)
Abbreviations: CI, confidence interval; LAZ, length-for-age z score; WAZ, weight-for-age z score.
aAdjusted for site, anthropometric measurement at enrollment, sex, WAMI (Water, Assets, Maternal 
Education, Income) score, mother’s age, presence of siblings, water treatment, routine hand-washing after 
child defecation, use of toilet paper, dirt floor, ownership of chickens, age at stopping exclusive breastfeeding, 
and percentage of surveillance stool samples that tested positive for Campylobacter and enteroaggregative E 
coli in the first 2 years of life.
bAll LAZ estimates excluded PKN (n = 1478).
cAlso adjusted for Giardia persistence in surveillance stool samples to assess independent effect of diarrhea 
with Giardia detection.
dThe difference between the 10th and 90th percentile of cumulative percent positivity across all sites was 38%, 
which represents a contrast between high and low Giardia exposure in the context of the MAL-ED cohort.
Table 3. Associations Between Giardia Detection and Markers of Inflammation and Gut Permeability in All Stool Samples Among 2076 Children in the 
MAL-ED Cohort With at Least 1 Biomarker Measurement
Site
LMZ Differencea 
(95% CI) (n = 4203)
ALA Differencea  
(95% CI) (n = 24 769)
MPO Differencea  
(95% CI) (n = 24 769)
NEO Differencea 
(95% CI) (n = 24 769)
AGP Differencea  
(95% CI) (n = 3550)
BGD 0.29 (0.00 to 0.59) 0.1 (−0.06 to 0.27) −0.22 (−0.43 to −0.02) −0.07 (−0.35 to 0.21) −0.44 (−12.01 to 11.14)
BRF 0.03 (−0.28 to 0.35) 0.00 (−0.22 to 0.23) −0.18 (−0.46 to 0.09) −0.20 (−0.42 to 0.02) 3.53 (−10.99 to 18.05)
INV 0.25 (0.04 to 0.46) −0.08 (−0.2 to 0.03) 0.00 (−0.12 to 0.13) −0.12 (−0.23 to −0.01) −1.05 (−8.66 to 6.57)
NEB 0.18 (−0.15 to 0.51) 0.11 (−0.03 to 0.24) 0.01 (−0.14 to 0.16) −0.10 (−0.21 to 0.01) −1.05 (−11.62 to 9.51)
PEL 0.23 (0.07 to 0.39) −0.02 (−0.16 to 0.11) −0.12 (−0.25 to 0.02) −0.19 (−0.30 to −0.08) −5.59 (−15.91 to 4.74)
PKN 0.19 (0.01 to 0.38) 0.05 (−0.06 to 0.16) 0.00 (−0.11 to 0.10) 0.00 (−0.09 to 0.10) 7.39 (0.35 to 14.43)
SAV 0.17 (−0.27 to 0.61) −0.01 (−0.19 to 0.18) 0.07 (−0.11 to 0.25) −0.20 (−0.38 to −0.01) 4.45 (−11.05 to 19.94)
TZH 0.01 (−0.42 to 0.44) 0.01 (−0.13 to 0.15) −0.06 (−0.19 to 0.08) −0.23 (−0.39 to −0.07) 5.20 (−7.40 to 17.80)
All 0.22 (0.12 to 0.32) −0.04 (−0.09 to 0.01) −0.09 (−0.14 to −0.03) −0.11 (−0.16 to −0.06) 1.83 (−1.82 to 5.47)
Abbreviations: AGP, α-1-acid glycoprotein (mg/dL); BGD, Dhaka, Bangladesh; BRF, Fortaleza, Brazil; CI, confidence interval; INV, Vellore, India; LMZ, urinary lactulose/mannitol excretion ratio z score (BRF cohort was the internal 
reference population); ALA, α-1-antitrypsin (log[mg/g]); MPO, myeloperoxidase (log[ng/mL]); NEB, Bhaktapur, Nepal; NEO: neopterin (log[nmol/L]); PEL, Loreto, Peru; PKN, Naushahro Feroze, Pakistan; SAV, Venda, South Africa; 
TZH, Haydom, Tanzania.
aAdjusted for site, age, stool consistency, sex, WAMI (Water, Assets, Maternal Education, Income) score, mother’s age, presence of siblings, water treatment, routine hand-washing after child defecation, use of toilet paper, dirt 
floor, ownership of chickens, percent exclusive breastfeeding, and presence of enteroaggregative E coli and/or Campylobacter in stool sample.
factor models from MAL-ED that compared high and low levels 
of Giardia exposures both defined by no detections in the first 
6 months (MAL-ED Network Investigators, unpublished data). 
Although other determinants might influence growth at later 
ages more strongly, targeting Giardia early in life might confer 
substantial benefit.
This study was limited by fewer surveillance stool samples 
tested in the second year of life when Giardia was most com-
mon. In addition, although more sensitive than microscopy, 
the EIA has a lower sensitivity than nucleic acid–based detec-
tion methods [37, 38]. We also did not use Assemblage typ-
ing, which might have helped distinguish persistent infection 
from reinfection and explain variability in clinical outcomes 
[39, 40]. Last, antihelminthic medications that are active 
against Giardia (eg, albendazole or mebendazole) were not 
recorded, although they might have been used at the individ-
ual level and potentially through mass treatment campaigns. 
Despite these limitations, the breadth of data available, 
including markers of gut inflammation and permeability, 
enabled robust analysis of the effects and potential mecha-
nisms of Giardia infection.
The MAL-ED study enabled a comprehensive description of 
Giardia epidemiology in children early in life across 8 diverse 
sites. In general, interventions to limit exposure might reduce 
Giardia burden better than treatment, because metronidazole 
only transiently reduced detection. Interventions to reduce 
early exposure (eg, through sustained exclusive breastfeeding) 
might have the greatest effect on long-term outcomes, given 
increased the susceptibility of children to the effects of Giardia 
during their first few months of life.
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